Synthetic production of circular dna vectors
US-2024409975-A1 · Dec 12, 2024 · US
US9234197B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9234197-B2 |
| Application number | US-201214349835-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2012 |
| Priority date | Oct 28, 2011 |
| Publication date | Jan 12, 2016 |
| Grant date | Jan 12, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides isolated polynucleotides that can serve as translation enhancing elements and their use in protein expression reagents and methods.
Opening claim text (preview).
We claim: 1. A recombinant viral or plasmid expression vector comprising (a) a translation enhancement element (TEE) of between 37 and 42 nucleotides in length, comprising the nucleic acid sequence of 5′-CATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO: 1); and (b) a cloning site located downstream of the TEE. 2. The expression vector of claim 1 , further comprising a promoter located upstream of the TEE. 3. The expression vector of claim 1 , further comprising a protein encoding nucleic acid cloned into the cloning site. 4. An isolated recombinant host cell comprising the expression vector of claim 1 . 5. A method for protein expression, comprising contacting the expression vector of claim 3 with reagents and under conditions for promoting expression of the protein encoded by the protein-encoding nucleic acid, and expressing the protein. 6. The method of claim 5 , wherein the protein is expressed in a cell-free translation system. 7. The method of claim 5 , wherein the protein is expressed by a recombinant host cell. 8. The method of claim 5 , wherein the expression vector is a recombinant vaccinia virus. 9. The method of claim 7 , wherein the recombinant host cell expresses the protein using non-viral-mediated translation. 10. An isolated recombinant virus, comprising the expression vector of claim 1 , wherein the expression vector is comprises a viral expression vector. 11. The recombinant virus of claim 10 , wherein the recombinant virus is a vaccinia virus, and the viral expression vector is a vaccinia virus expression vector. 12. The expression vector of claim 1 , wherein the TEE consists of 5′-CATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO: 1). 13. The expression vector of claim 1 , wherein the TEE consists of 5′-AGAACCATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO:2).
being an enhancer not forming part of the promoter region · CPC title
General methods for enhancing the expression · CPC title
for animal cells · CPC title
enhancing translation · CPC title
mammalian · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.